Loreto Martínez-González

5PUBLICATIONS
15CO-AUTHORS
Biologically active moleculesMolecular targetsNeurology and neuromuscular diseasesProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2025
11C-Labeling of a Flavanone Extracted from a South American Native Species for Evaluation of Its Interaction with GSK-3β.

Maia Zeni, Maria Daniela Santi, Florencia Arredondo

|Jan 11, 2024
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase.

Elisa Rojas-Prats, Loreto Martinez-Gonzalez, Carmen Gil

|Feb 10, 2023
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis.

Loreto Martinez-Gonzalez, Ana Martinez

|Aug 27, 2021
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.

Loreto Martínez-González, Claudia Gonzalo-Consuegra, Marta Gómez-Almería

|Feb 02, 2021
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles.

Elisa Rojas-Prats, Carlota Tosat-Bitrián, Loreto Martínez-González

Pageof 1

Frequent Collaborators

5 joint publications

Ana Martínez

2 joint publications

Elisa Rojas-Prats

1 joint publications

Carlota Tosat-Bitrián

1 joint publications

Vanesa Nozal